
EU-US tariff deal "unsatisfactory", "imbalanced"
Bernd Lange, chair of the European Parliament's Committee on International Trade, described the proposed framework, which includes a 15 per cent tariff on all EU exports to the US, as "unsatisfactory" and "significantly imbalanced."
The tariff rate, he noted, would represent a fourfold increase over current average levels, while the EU would commit to zero tariffs on US goods.
"This is a deal with a slant. Concessions have been made that are difficult to bear," Lange said in a statement on Sunday.
US President Donald Trump and European Commission President Ursula von der Leyen announced earlier in the day that the two sides had reached a trade agreement, under which the US would impose a baseline tariff of 15 per cent on EU goods.
Although both leaders described the deal as a step toward restoring "trade balance" and promoting more equitable two-way commerce, the agreement allows Washington to levy broad tariffs while securing zero-tariff access for a range of strategic American exports.
In contrast, the EU has pledged to purchase US$750 billion worth of American energy and commit an additional US$600 billion in investments in the US.
Lange noted that while Trump publicly declared a blanket 15 per cent tariff during remarks following the talks, he had earlier explicitly excluded certain sectors, including steel and pharmaceuticals.
He added that increased European purchases of US energy, particularly liquefied natural gas, were anticipated, as the EU continues efforts to reduce its reliance on Russian fossil fuels.
However, Lange criticised the US$600 billion in planned additional investments, including increased funding for US military technology, calling such measures contrary to European economic interests.
He likened the pressure tactics used in the deal to those Washington employed in recent negotiations with Japan.
"Overall, this deal will contribute to weakening the EU's economic development and harming its gross domestic product," he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
12 minutes ago
- New Straits Times
Pfizer, BioNTech lose UK appeal to Moderna in Covid-19 vaccine patent fight
LONDON: US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals Court in London upheld an earlier UK court decision in the long-running battle between the global pharma firms. It found that one of the European patents held by Moderna was invalid, but that a second one had been broken by Pfizer and its German partner BioNTech. "The judge made no error of law or principle" in the ruling handed down in July 2024, the Appeal Court judges wrote Friday, dismissing the appeal brought by the two companies. Pfizer quickly said it will appeal Friday's ruling to Britain's Supreme Court. "Today's UK Court of Appeal's decision does not change our unwavering stance that this patent is invalid," Pfizer said in a statement. "This decision has no immediate impact on Pfizer and BioNTech." Pfizer and BioNTech had argued that both the patents cited by Moderna were invalid, and neither had been infringed. Friday's decision could have wide implications for other cases involving the huge pharma companies in the United States, Germany, Belgium, the Netherlands and Ireland. Moderna said in a statement it was pleased with Friday's ruling and would "continue to pursue and enforce its patent rights globally to protect its innovative mRNA technology." A UK court was told last year the firms had spent £19 million (US$25 million) fighting their legal battles. In 2020, Pfizer and BioNTech's vaccine became the first ever mRNA vaccine approved for widespread use, and was swiftly deployed to combat the Covid pandemic. Scientists believe mRNA vaccines, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against many diseases. Traditional vaccines contain some form of the dead or inactivated target virus. Since the virus need not be grown in the lab, mRNA vaccines can in theory be developed at scale more quickly than traditional vaccines. In March, a German court in Duesseldorf also found Pfizer and BioNTech had violated a Moderna patent filed between 2010 to 2016 to make their vaccines. It ordered they must provide estimates of how much they had profited from breaking the patent as well as provide "appropriate compensation."--AFP


New Straits Times
2 hours ago
- New Straits Times
Colombian ex-president Uribe sentenced to 12 years house arrest
BOGOTA: A Colombian judge on Friday sentenced still-powerful former president Alvaro Uribe to 12 years of house arrest, capping a long and contentious career that defined Colombian politics for a generation. Uribe, 73, received the maximum possible sentence after being found guilty of witness tampering. The sentence marks the first time in Colombia's history that a former president has been convicted of a crime and sentenced. Uribe led Colombia from 2002 to 2010 and led a relentless military campaign against drug cartels and the FARC guerrilla army. He remains popular in Colombia, despite being accused by critics of working with armed right-wing paramilitaries to destroy leftist rebel groups. And he still wields considerable power over conservative politics in Colombia, playing kingmaker in the selection of new party leaders. He was found guilty of asking right-wing paramilitaries to lie about their alleged links to him. A judge on Monday found him guilty on two charges: interfering with witnesses and "procedural fraud." Uribe insists he is innocent and told the court that he will appeal the ruling. "You have treated me in the worst possible way" he told judge Sandra Heredia at the sentencing hearing. A law-and-order hardliner, Uribe was a close ally of the United States and retains ties to the American right. US Secretary of State Marco Rubio earlier decried Uribe's prosecution, claiming, without providing evidence, that it represented "the weaponisation of Colombia's judicial branch by radical judges." Recent opinion polls revealed him to be the South American country's best loved politician. The investigation against Uribe began in 2018 and has had numerous twists and turns, with several attorneys general seeking to close the case. It gained new impetus under Attorney General Luz Camargo, picked by current President Gustavo Petro — himself a former guerrilla and a political arch-foe of Uribe. More than 90 witnesses testified in the trial, which opened in May last year. During the trial, prosecutors produced evidence of at least one ex-paramilitary fighter who said he was contacted by Uribe to change his story. In 2019, thousands protested in Medellin and capital Bogota when he was first indicted in the case. On Monday, a smaller group of followers gathered outside the court wearing masks fashioned after his image and chanting: "Uribe, innocent!" The former president is also under investigation in other matters. He has testified before prosecutors in a preliminary probe into a 1997 paramilitary massacre of farmers when he was governor of the western Antioquia department. A complaint has also been filed against him in Argentina, where universal jurisdiction allows for the prosecution of crimes committed anywhere in the world. That complaint stems from Uribe's alleged involvement in the more than 6,000 executions and forced disappearances of civilians by the Colombian military when he was president.


Daily Express
2 hours ago
- Daily Express
Sultan Ibrahim's 2025 state visit to Russia marks historic moment
Published on: Saturday, August 02, 2025 Published on: Sat, Aug 02, 2025 By: Bernama Text Size: In Moscow, Sultan Ibrahim will receive a state welcome ceremony at the Kremlin, followed by an official meeting with Putin. Kuala Lumpur: His Majesty Sultan Ibrahim, the King of Malaysia, will make history as the first Malaysian Head of State to conduct an official visit to Russia from August 5 to 10, 2025. The visit comes at the invitation of Russian President Vladimir Putin. Istana Negara confirmed the visit in a statement, highlighting its significance in reinforcing diplomatic relations established in 1967. 'This visit also reflects the important role of the Malaysian monarchy in advancing the nation's diplomacy,' the statement said. The trip aims to expand cooperation in trade, higher education, technology, and innovation while fostering stronger people-to-people ties. As ASEAN Chair in 2025, Malaysia will also leverage the visit to enhance strategic cooperation with Russia, an ASEAN Dialogue Partner since 1996. In Moscow, Sultan Ibrahim will receive a state welcome ceremony at the Kremlin, followed by an official meeting with Putin. A state banquet hosted by the Russian President will also take place. His Majesty's itinerary includes visits to the Central Scientific Research Automobile and Automotive Engines Institute (NAMI) and the Tochka Kipeniya Technology and Innovation Hub. The King will then proceed to Kazan in the Republic of Tatarstan, a Muslim-majority autonomous region of Russia. There, he will meet with Rais Rustam Minnikhanov and tour a helicopter manufacturing facility. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia